Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype

被引：0

作者：

Marotta, G ^{[1
]}

Bigazzi, C ^{[1
]}

Bocchia, M ^{[1
]}

Forconi, F ^{[1
]}

Lauria, F ^{[1
]}

机构：

[1] Univ Siena, A Sclavo Hosp, Div Hematol, I-53100 Siena, Italy

来源：

HAEMATOLOGICA | 1998年 / 83卷 / 09期

关键词：

non Hodgkin lymphoma; ProMACE-CytaBOM regimen; long-term follow-up;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Long-lasting results achieved in 54 patients with aggressive non-Hodgkin lymphoma treated with Pro-MACE-CytaBOM regimen were evaluated. Twenty-four out of 54 (45%) patients achieved a complete remission and 13 of them are still in continuous remission with a median survival of 53.5 months. Interestingly, in 16 patients with intermediate grade histology we obtained an overall response rate of 100%.

引用

页码：853 / 854

页数：2

共 50 条

[1] LONG-TERM FOLLOW-UP OF CHOP-TREATED NON-HODGKIN LYMPHOMA OF HIGH-GRADE MALIGNANCY
HEINZ, R
BLUT, 1990, 60 (02): : 68 - 75
[2] Long-Term Follow-Up of Patients with Non-Hodgkin and Hodgkin Lymphomas with a Modified BEAM Conditioning Regimen
Armillas, Flor
Leon, Eucario
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S251 - S251
[3] A pilot study on the use of the ProMACE CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma
Baldini, L
Guffanti, A
Gobbi, P
Colombi, M
Federico, M
Avanzini, P
Cavanna, L
Pieresca, C
Silingardi, V
Maiolo, AT
CANCER, 1997, 79 (06) : 1234 - 1240
[4] Long-term follow-up of pathologic stage I large cell non-Hodgkin's lymphoma patients after primary radiotherapy
Lee, CK
Levitt, SH
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (02): : 93 - 98
[5] Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report
Micallef, Ivana N.
Stiff, Patrick J.
Nademanee, Auayporn P.
Maziarz, Richard T.
Horwitz, Mitchell E.
Stadtmauer, Edward A.
Kaufman, Jonathan L.
McCarty, John M.
Vargo, Rita
Cheverton, Peter D.
Struijs, Martin
Bolwell, Brian
DiPersio, John F.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (06) : 1187 - 1195
[6] Follow-up FDG PET/CT in Patients With Non-Hodgkin Lymphoma
Taghipour, Mehdi
Marcus, Charles
Nunna, Pratyusha
Subramaniam, Rathan M.
CLINICAL NUCLEAR MEDICINE, 2016, 41 (02) : E93 - E97
[7] High-dose Busulfan and Cyclophosphamide as a Conditioning Regimen for Autologous Peripheral Blood Stem Cell Transplantation in Childhood Non-Hodgkin Lymphoma Patients: A Long-term Follow-up Study
Andion, Maitane
Molina, Blanca
Gonzalez-Vicent, Marta
Alonso, Laura
Hernandez, Carmen
Lassaletta, Alvaro
Lopez-Ibor, Blanca
Villa, Marta
Angel Diaz, Miguel
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2011, 33 (03) : E89 - E91
[8] Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells
Witzens-Harig, Mathias
Heilmann, Conny
Hensel, Manfred
Kornacker, Martin
Benner, Axel
Haas, Rainer
Fruehauf, Stefan
Ho, Anthony D.
STEM CELLS, 2007, 25 (01) : 228 - 235
[9] Ten-Year Follow-Up of Pediatric Patients With Non-Hodgkin Lymphoma Treated With Allogeneic or Autologous Stem Cell Transplantation
Giulino-Roth, Lisa
Ricafort, Rosanna
Kernan, Nancy A.
Small, Trudy N.
Trippett, Tanya M.
Steinherz, Peter G.
Prockop, Susan E.
Scaradavou, Andromachi
Chiu, Michelle
O'Reilly, Richard J.
Boulad, Farid
PEDIATRIC BLOOD & CANCER, 2013, 60 (12) : 2018 - 2024
[10] Long-term follow-up of surgically treated gallbladder cancer patients
Puhalla, H
Wild, T
Bareck, E
Pokorny, H
Ploner, M
Soliman, T
Stremitzer, S
Depisch, D
Laengle, F
Gruenberger, T
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2002, 28 (08): : 857 - 863

← 1 2 3 4 5 →